Ophthalmology · North Miami Beach, FL
NPI
1952440372
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1400 NE Miami Gardens Dr, Suite 203
North Miami Beach, FL, 33179
Phone (305) 940-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
2,545 services
Medicare patients, 2024
867
Average age 76
Drug cost, 2024
$1.1M
6,999 prescriptions
Company payments, 2025
$1,916
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jesse S Pelletier was code 92014 (ophthalmological e&m), 587 times for 441 patients. In total Jesse S Pelletier billed 2,545 services in 43 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 587 | 441 | $84.51 | $50K |
| 99214 Office E&M - Established | Office | 487 | 413 | $68.03 | $33K |
| 92134 Computerized Ophthalmic Imaging | Office | 351 | 283 | $26.82 | $9,415 |
| 92133 Computerized Ophthalmic Imaging | Office | 177 | 174 | $22.53 | $3,988 |
| 92250 Angiography | Office | 164 | 162 | $22.91 | $3,757 |
| 92083 Vision, Hearing, and Speech Services | Office | 162 | 152 | $42.50 | $6,884 |
| 99204 Office E&M - New | Office | 82 | 82 | $104.09 | $8,535 |
| 67028 Intravitreal Injection | Office | 74 | 45 | $71.54 | $5,294 |
| 92136 Ultrasound - Nonspecific | Office | 71 | 66 | $25.49 | $1,810 |
| J7999 Compounded drug, not otherwise classified | Office | 45 | 33 | $63.68 | $2,866 |
| 66984 Cataract Surgery | Facility | 40 | 33 | $426.38 | $17K |
| 92012 Ophthalmological E&M | Office | 33 | 30 | $51.54 | $1,701 |
| 92004 Ophthalmological E&M | Office | 32 | 32 | $48.60 | $1,555 |
| 66821 Cataract Surgery | Office | 25 | 24 | $253.30 | $6,332 |
| 92025 Test - Miscellaneous | Office | 18 | 18 | $23.00 | $414 |
By year: 2022 $172K for 1,937 services; 2023 $186K for 2,135 services; 2024 $191K for 2,545 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jesse S Pelletier prescribed most often to Medicare patients was Latanoprost, with 1,840 prescriptions and refills. In total Jesse S Pelletier wrote 6,999 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,840 | 2,508 | 462 | $23K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 647 | 1,140 | 215 | $14K |
| Brimonidine Tartrate Generic | 575 | 864 | 169 | $6,733 |
| Prednisolone Acetate Generic | 437 | 558 | 242 | $23K |
| Restasis Cyclosporine | 419 | 503 | 142 | $297K |
| Moxifloxacin Moxifloxacin Hcl | 310 | 315 | 193 | $7,141 |
| Vyzulta Latanoprostene Bunod | 221 | 285 | 57 | $71K |
| Loteprednol Etabonate Generic | 207 | 228 | 117 | $29K |
| Dexamethasone Sodium Phosphate Generic | 195 | 229 | 123 | $8,078 |
| Ilevro Nepafenac | 185 | 269 | 128 | $69K |
| Timolol Maleate Generic | 169 | 269 | 52 | $1,741 |
| Lumigan Bimatoprost | 159 | 243 | 49 | $63K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 152 | 155 | 113 | $2,085 |
| Xiidra Lifitegrast | 143 | 169 | 49 | $116K |
| Dorzolamide Hcl Generic | 129 | 234 | 39 | $3,034 |
Brand drugs: - claims; generic drugs: 3,815 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesse S Pelletier $1,916 ($1,916 in general payments such as food, travel and fees) from 14 companies. The largest payer was New World Medical,Inc. with $445.
| Company | Payments | Amount |
|---|---|---|
| New World Medical,Inc. | 6 | $445 |
| Abbvie Inc. ABBV | 19 | $366 |
| Alcon Vision LLC ALC | 7 | $286 |
| Oyster Point Pharma, Inc. | 12 | $253 |
| Mallinckrodt Hospital Products Inc. | 1 | $119 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $111 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $76.41 |
| Dompe US, Inc. | 2 | $54 |
| Biotissue Holdings Inc. | 2 | $47.14 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $46.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.